Reports
Reports
Sale
The global mHealth market size was valued at USD 70.2 billion in 2023, driven by the increasing technological advancement in healthcare across the globe. The market size is anticipated to grow at a CAGR of 18.86% during the forecast period of 2024-2032 to achieve a value of USD 329.1 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of chronic diseases has been contributing significantly to the rising demand for healthcare services, and applications such as chronic disease management and remote monitoring. These services are expected to enhance mHealth market growth as demand for these services is constantly rising.
Institutes and companies are increasingly investing in the development of digital healthcare services as it is widely accepted that these services have helped doctors provide better care and improve healthy lifestyles. Further, people are becoming more aware of the importance of early diagnosis of diseases, which allows patients to take preventive measures. Mobile medical platforms have risen in preference among people for consultation and book slots for consultation due to the convenience they provide.
The healthcare sector is increasingly becoming accustomed to patient-centered treatment and medication. This can provide excellent market enhancement opportunities as mHealth services can significantly help with this shift in trend by easily providing detailed information about the patient and tracking treatment records. Additionally, governments around the world are initiating plans and collaborating with institutions to support the development of remote digital healthcare. The efforts have dramatically increased in scale after the COVID-19 pandemic.
Rising Innovations Aiding the mHealth Market Demand
In June 2023, Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the development of its proprietary Bio-RFID™ technology, the Generation (Gen) 1 Device. Gen 1 incorporates Know Labs’ Bio-RFID sensor, proven as technically feasible and stable in delivering repeatable results in measuring blood glucose when used in a lab environment in a portable device.
Due to the absence of medical-grade, commercially available, non-invasive devices for measuring blood glucose, completion of Gen 1 is expected to make Know Labs the first company to deliver the world’s first FDA-approved non-invasive blood glucose monitor for the billions of people living with diseases such as diabetes and pre-diabetes worldwide. This development is further poised to boost mHealth market growth due to the availability of an innovative and non-invasive device that is convenient to use in the market. The market growth is also attributed to the increasing preference for minimally invasive blood glucose monitoring devices.
Gen-1 is like a portable research lab that can collect data in substantial amounts. With the help of this enormous amount of data, the device can be put to the test in several situations to perform better and learn about the efficacy it provides, which will be crucial for the users so that they can rely on the device.
Rising Product Launches to Aid the Market Growth
In November 2023, DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, launched a new smart blood sugar meter for Apple iPhone 15 users to support ongoing engagement with new and existing members.
Additionally, In August 2023, Suki, the leader in voice artificial intelligence (AI) technology for healthcare, announced an enhancement for Cerner like the bidirectional ambient sync for Epic. The development of Suki Assistant empowers Cerner users to accelerate the creation of clinical documentation with ease and efficiency, enabling reduced cognitive load and documentation time. The rising introduction of such innovative products is likely to contribute significantly to the mHealth market share.
With bidirectional sync, doctors can work seamlessly across Cerner and Suki to stay productive and efficient with their documentation, providing incredible flexibility in their workflow. Such developments align right with the goals of mHealth which is to focus on leveraging technology to make healthcare processes more efficient and convenient.
Strategic Collaborations Between Market Players
In December 2023, Medtronic plc (opens new window) (NYSE: MDT), a global leader in healthcare technology, announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius™ intelligent endoscopy module by offering continued innovation and scalable healthcare advancements for patients and caregivers globally.
Integration of advanced technologies such as artificial intelligence (AI) aligns with advancements in mHealth, a trend poised to expand the global mHealth market reach. The focus on expanding global reach and advancing healthcare aligns right with the broader goals of mHealth to provide accessible and innovative healthcare solutions on a global level with this exclusive collaboration.
Such collaborations focused on bringing innovation to healthcare to enable better and more effective diagnostic resources and procedures are expected to drive market growth during the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Application
Market Breakup by Stakeholders
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is leading the regional market due to factors such as increasing incidence of chronic diseases, rising geriatric population, growing healthcare expenditure, and increasing integration of advanced technologies in the healthcare domain. In addition, favorable government initiatives and the growing adoption of mobile healthcare applications are accelerating the demand for mHealth services in the regional market.
In October 2023, Cedars-Sinai launched a new artificial intelligence-driven mHealth application for patients in California providing virtual care options for various clinical conditions. The Cedars-Sinai Connect app offers 24/7 virtual access to healthcare professionals for urgent care and same-day appointments for primary care. Users can access the app to seek care for several conditions, including colds, headaches, anxiety, type 2 diabetes, wellness visits, and specialist referrals.
The app offers a step-by-step process to assist new and existing patients input their health-related details and symptoms. Once the information is submitted, the app evaluates the data and forwards it to a healthcare professional for review. The patient can then communicate with a healthcare provider through a video call.
This development aligns perfectly with mHealth which is focused on increasing productivity and providing convenience to its users through leveraging advanced technologies in healthcare.
In April 2023, Abbott (NYSE: ABT) announced the FDA approval for its FreeStyle Libre® 3 integrated continuous glucose monitoring (iCGM) system, featuring the world's smallest, thinnest, and most discreet glucose sensor. With the FDA's clearance of a standalone reader, Abbott is working to get the FreeStyle Libre 3 system added to Medicare's list of covered systems as soon as possible.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by Stakeholder |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global mHealth Market Overview
3.1 Global mHealth Market Historical Value (2017-2023)
3.2 Global mHealth Market Forecast Value (2024-2032)
4 Global mHealth Market (2017-2032) Landscape
4.1 Global mHealth Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global mHealth Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Mode of Application
4.2.3 Analysis by Stakeholder
5 Global mHealth Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global mHealth Market Segmentation
6.1 Global mHealth Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 mHealth Apps
6.1.2.1 Healthcare Apps
6.1.2.2 Medication Management Apps
6.1.3 mHealth Devices
6.1.3.1 Blood Glucose Monitors
6.1.3.2 Cardiac Monitors
6.1.3.3 Hemodynamic Monitors
6.1.3.4 Neurological Monitors
6.1.3.5 Respiratory Monitors
6.1.3.6 Body and Temperature Monitors
6.1.3.7 Remote Patient Monitoring Devices
6.1.3.8 Other Devices
6.1.4 mHealth Services
6.1.4.1 Treatment Services
6.1.4.1.1 Independent Aging Solutions
6.1.4.1.2 Chronic Disease Management
6.1.4.2 Diagnostic Services
6.1.4.3 Monitoring Services
6.1.4.3.1 Remote Patient Monitoring Devices
6.1.4.3.2 Medical Call Centers Manned by Healthcare Professionals
6.1.4.3.3 Teleconsultation
6.1.4.3.4 Post Acute Care Services
6.1.4.4 Wellness and Fitness Solutions
6.1.4.5 Other Services
6.2 Global mHealth Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Cardiovascular
6.2.3 Diabetes
6.2.4 Respiratory
6.2.5 Neurology
6.2.6 Others
6.3 Global mHealth Market (2017-2032) by Stakeholder
6.3.1 Market Overview
6.3.2 Mobile Operators
6.3.3 Device Vendors
6.3.4 Healthcare Providers
6.3.5 Application and Content Players
6.4 Global mHealth Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America mHealth Market (2017-2032)
7.1 North America mHealth Market (2017-2032) by Mode of Application
7.1.1 Market Overview
7.1.2 Cardiovascular
7.1.3 Diabetes
7.1.4 Respiratory
7.1.5 Neurology
7.1.6 Others
7.2 North America mHealth Market (2017-2032) by Stakeholder
7.2.1 Market Overview
7.2.2 Mobile operators
7.2.3 Device Vendors
7.2.4 Healthcare Providers
7.2.5 Application and Content Players
7.3 North America mHealth Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe mHealth Market (2017-2032)
8.1 Europe mHealth Market (2017-2032) by Application
8.1.1 Market Overview
8.1.2 Cardiovascular
8.1.3 Diabetes
8.1.4 Respiratory
8.1.5 Neurology
8.1.6 Others
8.2 Europe mHealth Market (2017-2032) by Stakeholder
8.2.1 Market Overview
8.2.2 Mobile operators
8.2.3 Device Vendors
8.2.4 Healthcare Providers
8.2.5 Application and Content Players
8.3 Europe mHealth Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific mHealth Market (2017-2032)
9.1 Asia Pacific mHealth Market (2017-2032) by Application
9.1.1 Market Overview
9.1.2 Cardiovascular
9.1.3 Diabetes
9.1.4 Respiratory
9.1.5 Neurology
9.1.6 Others
9.2 Asia Pacific mHealth Market (2017-2032) by Stakeholder
9.2.1 Market Overview
9.2.2 Mobile operators
9.2.3 Device Vendors
9.2.4 Healthcare Providers
9.2.5 Application and Content Players
9.3 Asia Pacific mHealth Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America mHealth Market (2017-2032)
10.1 Latin America mHealth Market (2017-2032) by Application
10.1.1 Market Overview
10.1.2 Cardiovascular
10.1.3 Diabetes
10.1.4 Respiratory
10.1.5 Neurology
10.1.6 Others
10.2 Latin America mHealth Market (2017-2032) by Stakeholder
10.2.1 Market Overview
10.2.2 Mobile operators
10.2.3 Device Vendors
10.2.4 Healthcare Providers
10.2.5 Application and Content Players
10.3 Latin America mHealth Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa mHealth Market (2017-2032)
11.1 Middle East and Africa mHealth Market (2017-2032) by Application
11.1.1 Market Overview
11.1.2 Cardiovascular
11.1.3 Diabetes
11.1.4 Respiratory
11.1.5 Neurology
11.1.6 Others
11.2 Middle East and Africa mHealth Market (2017-2032) by Stakeholder
11.2.1 Market Overview
11.2.2 Mobile operators
11.2.3 Device Vendors
11.2.4 Healthcare Providers
11.2.5 Application and Content Players
11.3 Middle East and Africa mHealth Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Koninklijke Philips N.V.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Apple, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 AirStrip Technologies Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 AliveCor India
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Omron Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 BioTelemetry, a Philips Company
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Athenahealth, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 AgaMatrix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Withings
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iHealth Labs, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cerner Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 ZTE Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Cisco Systems, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 AT&T Intellectual Property
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Qualcomm Technologies, Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
List not exhaustive
18 Global mHealth Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
*The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 70.2 billion in 2023, driven by the increasing advancement.
The global mHealth market size is anticipated to grow at a CAGR of 18.9% during the forecast period of 2024-2032 and reach a market value of USD 329.1 billion by 2032.
The increasing prevalence of chronic diseases, growing healthcare expenditure, rising geriatric population, technological advancements, product launches, FDA approvals, and government initiatives are among the major factors aiding the market demand.
The increasing number of strategic collaborations between market players to provide the best technology to increase efficiency and convenience for its users in healthcare such as Medtronic plc partnering with Cosmo Intelligent Medical Devices is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
mHealth is available in the market as applications, services, and devices.
mHealth can find wide applications in medical conditions such as cardiovascular, diabetes, respiratory, and neurology, among others.
Stakeholders include mobile operators, device vendors, healthcare providers, and application and content players.
Key players involved in the market are Koninklijke Philips N.V., Abbott, Medtronic, Apple, Inc., AirStrip Technologies Inc., AliveCor India, Omron Corporation, BioTelemetry, a Philips Company, Athenahealth, Inc., AgaMatrix, Withings, iHealth Labs, Inc., Cerner Corporation, ZTE Corporation, Cisco Systems, Inc., Qualcomm Technologies, Inc., and AT&T Intellectual Property.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.